Published in Philos Trans R Soc Lond B Biol Sci on August 29, 2007
Engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A (2009) 2.48
Electrical stimulation systems for cardiac tissue engineering. Nat Protoc (2009) 1.97
A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. Tissue Eng Part A (2012) 1.95
The effect of bioengineered acellular collagen patch on cardiac remodeling and ventricular function post myocardial infarction. Biomaterials (2013) 1.68
Cardiac tissue engineering using perfusion bioreactor systems. Nat Protoc (2008) 1.65
Engineered electrical conduction tract restores conduction in complete heart block: from in vitro to in vivo proof of concept. J Am Coll Cardiol (2014) 1.43
Bioengineering heart muscle: a paradigm for regenerative medicine. Annu Rev Biomed Eng (2011) 1.26
Human embryonic stem cells and cardiac repair. Transplant Rev (Orlando) (2008) 1.15
Biomaterial strategies for alleviation of myocardial infarction. J R Soc Interface (2011) 1.13
Functional scaffold-free 3-D cardiac microtissues: a novel model for the investigation of heart cells. Am J Physiol Heart Circ Physiol (2012) 1.07
Hybrid PGS-PCL microfibrous scaffolds with improved mechanical and biological properties. J Tissue Eng Regen Med (2011) 1.07
Emerging technologies for assembly of microscale hydrogels. Adv Healthc Mater (2012) 1.06
Highly Elastic Micropatterned Hydrogel for Engineering Functional Cardiac Tissue. Adv Funct Mater (2013) 1.04
Surface-patterned electrode bioreactor for electrical stimulation. Lab Chip (2010) 1.03
Cross talk between cardiac myocytes and fibroblasts: from multiscale investigative approaches to mechanisms and functional consequences. Am J Physiol Heart Circ Physiol (2012) 1.02
Drug releasing systems in cardiovascular tissue engineering. J Cell Mol Med (2009) 0.95
Spatial and temporal analysis of extracellular matrix proteins in the developing murine heart: a blueprint for regeneration. Tissue Eng Part A (2013) 0.93
Customized biomimetic scaffolds created by indirect three-dimensional printing for tissue engineering. Biofabrication (2013) 0.90
Functional differences in engineered myocardium from embryonic stem cell-derived versus neonatal cardiomyocytes. Stem Cell Reports (2013) 0.89
Myocardial scaffold-based cardiac tissue engineering: application of coordinated mechanical and electrical stimulations. Langmuir (2013) 0.88
Biomaterial based cardiac tissue engineering and its applications. Biomed Mater (2015) 0.88
Structural and functional plasticity in long-term cultures of adult ventricular myocytes. J Mol Cell Cardiol (2013) 0.83
Channelled scaffolds for engineering myocardium with mechanical stimulation. J Tissue Eng Regen Med (2011) 0.82
Addition of perfluorocarbons to alginate hydrogels significantly impacts molecular transport and fracture stress. J Biomed Mater Res A (2012) 0.81
Cardiomyocytes in vitro adhesion is actively influenced by biomimetic synthetic peptides for cardiac tissue engineering. Tissue Eng Part A (2011) 0.80
Lost in translation: what is limiting cardiomyoplasty and can tissue engineering help? Curr Stem Cell Res Ther (2009) 0.79
Introduction. Bioengineering the heart. Philos Trans R Soc Lond B Biol Sci (2007) 0.79
Directed stem cell differentiation: the role of physical forces. Cell Commun Adhes (2010) 0.79
Electrical Field Stimulation with a Novel Platform: Effect on Cardiomyocyte Gene Expression but not on Orientation. Int J Biomed Sci (2012) 0.77
Fabrication and characterization of tough elastomeric fibrous scaffolds for tissue engineering applications. Conf Proc IEEE Eng Med Biol Soc (2010) 0.77
Tissue-Engineering for the Study of Cardiac Biomechanics. J Biomech Eng (2016) 0.76
Electrical and mechanical stimulation of cardiac cells and tissue constructs. Adv Drug Deliv Rev (2015) 0.76
Cardiovascular nanomedicine: a posse ad esse. Methodist Debakey Cardiovasc J (2012) 0.75
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Bone marrow cells regenerate infarcted myocardium. Nature (2001) 21.24
Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell (2003) 18.09
Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature (2005) 9.44
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature (2004) 8.87
Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res (2004) 8.41
Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature (2004) 8.36
Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A (2003) 7.87
Regenerating the heart. Nat Biotechnol (2005) 5.58
Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol (2003) 4.91
Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med (2006) 4.74
Tissue engineering of a differentiated cardiac muscle construct. Circ Res (2002) 4.50
Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol (2004) 4.50
A tough biodegradable elastomer. Nat Biotechnol (2002) 4.35
Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A (2004) 4.13
Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest (1996) 3.87
Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin. Circ Res (2003) 3.84
Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol (2002) 3.79
Incidence of congenital heart disease: I. Postnatal incidence. Pediatr Cardiol (1995) 3.48
Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med (1998) 3.28
Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science (1994) 3.24
Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res (2002) 3.10
Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res (2007) 2.74
Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation (1999) 2.68
Incidence of congenital heart disease: II. Prenatal incidence. Pediatr Cardiol (1995) 2.56
Medium perfusion enables engineering of compact and contractile cardiac tissue. Am J Physiol Heart Circ Physiol (2003) 2.42
Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J (1997) 2.33
Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation (2000) 2.25
Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng (2006) 2.20
Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am J Physiol (1999) 2.19
Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution. Cytobios (1980) 2.09
Pulsatile cardiac tissue grafts using a novel three-dimensional cell sheet manipulation technique functionally integrates with the host heart, in vivo. Circ Res (2006) 2.02
Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng (2006) 2.01
Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng (1999) 2.00
Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng (2000) 1.96
Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. Am J Physiol Heart Circ Physiol (2001) 1.90
Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci U S A (2001) 1.81
High-density seeding of myocyte cells for cardiac tissue engineering. Biotechnol Bioeng (2003) 1.77
Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J (2000) 1.74
Survival and function of bioengineered cardiac grafts. Circulation (1999) 1.72
Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am J Physiol Heart Circ Physiol (2004) 1.65
Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium? Circulation (1996) 1.64
Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest (1993) 1.58
Morphometric study of early postnatal development in the left and right ventricular myocardium of the rat. II. Tissue composition, capillary growth, and sarcoplasmic alterations. Circ Res (1980) 1.47
Perfusion improves tissue architecture of engineered cardiac muscle. Tissue Eng (2002) 1.46
Cardiac grafting of engineered heart tissue in syngenic rats. Circulation (2002) 1.43
Cardiac fibrosis as a cause of diastolic dysfunction. Herz (2002) 1.35
The cardiac muscle cell. Bioessays (2000) 1.33
Epidemiology of congenital heart disease in the United States. Am Heart J (1994) 1.32
Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation (2002) 1.32
Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells. Circulation (2006) 1.27
Contribution of collagen matrix to passive left ventricular mechanics in isolated rat hearts. Am J Physiol (1994) 1.24
Influence of electrical axis of stimulation on excitation of cardiac muscle cells. Circ Res (1991) 1.23
Cultivation in rotating bioreactors promotes maintenance of cardiac myocyte electrophysiology and molecular properties. Tissue Eng (2003) 1.23
Cellular cardiomyoplasty improves survival after myocardial injury. Circulation (2002) 1.21
Cardiomyocyte transplantation improves heart function. Ann Thorac Surg (1996) 1.20
PDGF mediates cardiac microvascular communication. J Clin Invest (1998) 1.15
Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cell Cardiol (2001) 1.14
Cardiac organogenesis in vitro: reestablishment of three-dimensional tissue architecture by dissociated neonatal rat ventricular cells. Tissue Eng (1999) 1.14
Dance band on the Titanic: biomechanical signaling in cardiac hypertrophy. Circ Res (2002) 1.12
Effects of oxygen on engineered cardiac muscle. Biotechnol Bioeng (2002) 1.10
Construction of a bioengineered cardiac graft. J Thorac Cardiovasc Surg (2000) 1.08
Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: role of reactive oxygen species and NADPH oxidase. Circulation (2001) 1.03
In vitro engineering of heart muscle: artificial myocardial tissue. J Thorac Cardiovasc Surg (2002) 0.94
Functional capillary density in normal and transplanted rat hearts. Can J Physiol Pharmacol (1982) 0.93
Myosin heavy chain expression in embryonic cardiac cell cultures. Dev Biol (1986) 0.92
The cardiac endothelium: cardioactive mediators. Prog Cardiovasc Dis (1997) 0.92
Myocardial expression of atrial natriuretic factor gene in early stages of hamster cardiomyopathy. Mol Cell Biochem (1993) 0.91
The effect of growth and aging on functional capillary supply of the rat heart. Growth (1982) 0.91
Can grafted cardiomyocytes colonize peri-infarct myocardial areas? Circulation (1996) 0.91
Fetal cell transplantation: a comparison of three cell types. J Thorac Cardiovasc Surg (1999) 0.90
Numerical density of cardiomyocytes in chronic nitric oxide synthesis inhibition. Pathobiology (2000) 0.86
Bradykinin and endothelial-cardiac myocyte interactions in ischemic preconditioning. Am J Cardiol (1997) 0.84
Electrical coupling of cardiac myocyte cell sheets to the heart. Circ Res (2006) 0.84
Microcirculation of the epimyocardial layer of the heart. I. A method for in vivo observation of the microcirculation of superficial ventricular myocardium of the heart and capillary flow pattern under normal and hypoxic conditions. Pflugers Arch (1978) 0.83
Inhibition of myocardial crossbridge cycling by hypoxic endothelial cells: a potential mechanism for matching oxygen supply and demand? Circ Res (1997) 0.81
Pharmacological modulation of cardiac fibroblast function. Herz (1995) 0.79
Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species. Science (2001) 10.93
Biodegradable long-circulating polymeric nanospheres. Science (1994) 7.46
Functional arteries grown in vitro. Science (1999) 6.08
Generation of single optical plasmons in metallic nanowires coupled to quantum dots. Nature (2007) 3.50
Large porous particles for pulmonary drug delivery. Science (1997) 3.35
A Method for Estimating Volume-Surface Ratios. Science (1949) 3.31
New challenges in biomaterials. Science (1994) 2.85
DTI and MTR abnormalities in schizophrenia: analysis of white matter integrity. Neuroimage (2005) 2.84
Polymers for the sustained release of proteins and other macromolecules. Nature (1976) 2.81
Stimulation of neurite outgrowth using an electrically conducting polymer. Proc Natl Acad Sci U S A (1997) 2.74
Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature (1992) 2.73
Solution structure of the homodimeric core domain of Escherichia coli histidine kinase EnvZ. Nat Struct Biol (1999) 2.72
Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases. Science (1996) 2.71
Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res (1991) 2.70
NMR structure of the histidine kinase domain of the E. coli osmosensor EnvZ. Nature (1998) 2.69
Photoencapsulation of chondrocytes in poly(ethylene oxide)-based semi-interpenetrating networks. J Biomed Mater Res (2000) 2.67
Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res (2000) 2.64
Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet (1999) 2.62
Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science (1983) 2.47
Biodegradable polymer scaffolds for tissue engineering. Biotechnology (N Y) (1994) 2.47
A controlled-release microchip. Nature (1999) 2.39
Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci U S A (1993) 2.27
Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials (1996) 2.27
Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection. Aliment Pharmacol Ther (2014) 2.22
Enzymatic degradation of glycosaminoglycans. Crit Rev Biochem Mol Biol (1995) 2.21
Nanometre-scale thermometry in a living cell. Nature (2013) 2.20
Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. Proc Natl Acad Sci U S A (1991) 2.19
Bioreactor cultivation conditions modulate the composition and mechanical properties of tissue-engineered cartilage. J Orthop Res (1999) 2.19
Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am J Physiol (1999) 2.19
Lipid-based nanotherapeutics for siRNA delivery. J Intern Med (2010) 2.15
Fabry - Perot interference in a nanotube electron waveguide. Nature (2001) 2.14
Formulation and physical characterization of large porous particles for inhalation. Pharm Res (1999) 2.10
Ultrasound-mediated transdermal protein delivery. Science (1995) 2.07
A hybrid artificial neural network as a software sensor for optimal control of a wastewater treatment process. Water Res (2001) 2.05
Dynamic cell seeding of polymer scaffolds for cartilage tissue engineering. Biotechnol Prog (1998) 2.03
Accelerated discovery of synthetic transfection vectors: parallel synthesis and screening of a degradable polymer library. J Am Chem Soc (2001) 2.02
Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Ann Neurol (1989) 2.01
Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng (1999) 2.00
Transdermal photopolymerization for minimally invasive implantation. Proc Natl Acad Sci U S A (1999) 1.99
PNG1, a yeast gene encoding a highly conserved peptide:N-glycanase. J Cell Biol (2000) 1.98
Signal transduction via the histidyl-aspartyl phosphorelay. Genes Cells (1997) 1.96
Synthesis of superporous hydrogels: hydrogels with fast swelling and superabsorbent properties. J Biomed Mater Res (1999) 1.95
Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric (2013) 1.94
Bioadhesive polymers as platforms for oral controlled drug delivery II: synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers. J Pharm Sci (1985) 1.94
Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. Am J Physiol Heart Circ Physiol (2001) 1.90
Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res (1993) 1.88
Polymers for sustained macromolecule release: procedures to fabricate reproducible delivery systems and control release kinetics. J Pharm Sci (1980) 1.86
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials (2000) 1.85
Morphologic and mechanical characteristics of engineered bovine arteries. J Vasc Surg (2001) 1.84
Gastric retentive drug-delivery systems. Crit Rev Ther Drug Carrier Syst (1998) 1.81
Switching from differentiation to growth in hepatocytes: control by extracellular matrix. J Cell Physiol (1992) 1.79
Isolations of a cartilage factor that inhibits tumor neovascularization. Science (1976) 1.79
Identification of an inhibitor of neovascularization from cartilage. Science (1990) 1.78
Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative. Hypertension (2000) 1.77
Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials (1996) 1.76
Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg (1998) 1.76
Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini. Proc Natl Acad Sci U S A (2001) 1.76
Silk fibroin as an organic polymer for controlled drug delivery. J Control Release (2006) 1.71
Cytoskeletal filament assembly and the control of cell spreading and function by extracellular matrix. J Cell Sci (1995) 1.71
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Regulation of Btk by Src family tyrosine kinases. Mol Cell Biol (1996) 1.66
Gastric retention properties of superporous hydrogel composites. J Control Release (2000) 1.64
Chromosomal mapping of human creatine kinase (brain type) using human-rodent somatic cell hybrids. Cytogenet Cell Genet (1980) 1.63
The stimulation of DNA synthesis and cell division in chondrocytes and 3T3 cells by a growth factor isolated from cartilage. Exp Cell Res (1977) 1.60
A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J Pharm Sci (1997) 1.58
Laminated three-dimensional biodegradable foams for use in tissue engineering. Biomaterials (1993) 1.57
Transdermal monitoring of glucose and other analytes using ultrasound. Nat Med (2000) 1.57
Tissue engineering of cartilage in space. Proc Natl Acad Sci U S A (1997) 1.57
Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain. Immunity (1995) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg (1988) 1.55
Comparison of 2-year angiographic outcomes of stent- and nonstent-assisted coil embolization in unruptured aneurysms with an unfavorable configuration for coiling. AJNR Am J Neuroradiol (2011) 1.53
Transdermal photopolymerization of poly(ethylene oxide)-based injectable hydrogels for tissue-engineered cartilage. Plast Reconstr Surg (1999) 1.52
Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res (1997) 1.51
Is minimal change esophagitis really part of the spectrum of endoscopic findings of gastroesophageal reflux disease? A prospective, multicenter study. Endoscopy (2011) 1.51
[MRI with supermagnetic iron particles versus double-spiral CT in identification of malignant liver lesions]. Rofo (1998) 1.51
Rad23 provides a link between the Png1 deglycosylating enzyme and the 26 S proteasome in yeast. J Biol Chem (2001) 1.49
A new plastic receptacle for solid phase immunoassays. J Immunol Methods (1978) 1.49
Fallopian tube torsion: laparoscopic evaluation and treatment of a rare gynecological entity. J Am Board Fam Pract (2001) 1.49
Controlled and modulated release of basic fibroblast growth factor. Biomaterials (1991) 1.48
Collagen in tissue-engineered cartilage: types, structure, and crosslinks. J Cell Biochem (1998) 1.47
Sucrose intake and coronary heart-disease. Lancet (1968) 1.47
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Level of in utero cocaine exposure and neonatal ultrasound findings. Pediatrics (1999) 1.45
Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg (1991) 1.44
Integration of engineered cartilage. J Orthop Res (2001) 1.44
Differential activation of potato 3-hydroxy-3-methylglutaryl coenzyme A reductase genes by wounding and pathogen challenge. Plant Cell (1991) 1.44
Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. J Biomed Mater Res (1993) 1.44
Bacterial inactivation by using near- and supercritical carbon dioxide. Proc Natl Acad Sci U S A (1999) 1.43
Purification and characterization of heparinase from Flavobacterium heparinum. J Biol Chem (1985) 1.43
The most useful findings for diagnosing acute appendicitis on contrast-enhanced helical CT. Acta Radiol (2003) 1.43
Transdermal drug delivery using low-frequency sonophoresis. Pharm Res (1996) 1.42
Chondrogenesis in a cell-polymer-bioreactor system. Exp Cell Res (1998) 1.42